+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Healthcare Licensing with China: China - Small/MidCap Most Recent 25

  • ID: 5187920
  • Report
  • October 2020
  • Region: Global, China
  • 90 pages
  • Life Science Licensing
This trends report provides a comprehensive analysis on the most recent 25 licensing deals and negotiations reported for the Small/MidCap healthcare companies of China from January 1, 2019 to September 30, 2020, categorized and summarized by various important aspects such as healthcare sub-sectors, medicine groups, across key regions, licensing payment arrangements, and worldwide vs domestic licensing. Such detailed analysis helps to understand the licensing trends and directions during this time period in the healthcare segment of China Small/MidCap sector. The report is extremely useful for the healthcare company executives negotiating licensing deals, as well as for the investors analyzing varied kinds of transaction options for licensing deals in the China Small/MidCap sector. The report provides comprehensive information with twenty one months’ healthcare licensing transactions analyzed at one place and all four healthcare sub-sectors covered. The licensing trends and directions are summarized here after an in-depth analysis based on the comprehensive news gathering followed by insightful research.
Note: Product cover images may vary from those shown
Introduction

Research Design

Chapter 1: Analysis of most recent 25 healthcare inventions in China (Small/MidCap) sector licensed during last twenty one months
1.1 Healthcare sub-sectors with most licensing deals
1.2 Medicine groups most active in licensing deals
1.3 Licensing payment arrangements most followed
1.4 Worldwide licensing vs domestic licensing

Chapter 2: Analysis of most recent 25 licensing deals in China (Small/MidCap) sector by key attributes during last twenty one months
2.1 For each of the healthcare sub-sectors
2.2 For each of the medicine groups
2.3 Across each of the regions

Chapter 3: Summary and conclusions

Appendices
Appendix 1 Most recent 25 healthcare inventions licensed in China (Small/MidCap) sector during last twenty one months - By company name
Appendix 2 List of companies/institutes covered - By country and company name
Appendix 3 List of companies/institutes covered - By sub-industry and company name
Appendix 4 List of companies/institutes covered - By medicine group and company name
Appendix 5 List of companies/institutes covered - By terms of payment and company name
Appendix 6 Licensing deals discontinued in China (Small/MidCap) sector during last twenty one months
Note: Product cover images may vary from those shown

Loading
LOADING...

Loading
LOADING...

Adroll
adroll